Form 4: Columbia Financial CEO Boosts Stake via Deferral Plan
Insider Transaction Report
Columbia Financial, Inc.'s President & CEO, Thomas J. Kemly, acquired 116.8059 shares of common stock at $15.3 per share through a stock-based deferral plan.
Summary
- Thomas J. Kemly, President & CEO and Director of Columbia Financial, Inc. (CLBK), acquired 116.8059 shares of common stock on January 9, 2026.
- The shares were purchased at a price of $15.3 per share through the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan.
- Following this transaction, Mr. Kemly beneficially owns a total of 66,605.8569 shares indirectly through the Stock-Based Deferral Plan.
- His total beneficial ownership of common stock also includes 233,808 shares held directly, 40,946 shares via 401(k), 7,620 shares via ESOP, 32,597 shares via SERP, 41,572 shares via SIM, 5,933 shares via Spouse, 43,411 shares via Stock Award II, 50,686 shares via Stock Award III, and 54,690 shares via Stock Award IV.
- Mr. Kemly also holds various stock options, including 656,471 fully vested options with an exercise price of $15.6, expiring July 23, 2029.
- Additional stock options include 37,894 options at $15.94 (vesting from May 1, 2024), 37,168 options at $16.49 (vesting from March 6, 2025), and 94,749 options at $16.23 (vesting from March 3, 2026).
Sentiment
Score: 7
Explanation: The acquisition of shares by the President & CEO, even through a deferral plan, generally signals confidence in the company's future performance and aligns management's interests with shareholders. The detailed equity incentive plans also reflect a structured approach to executive compensation.
Positives
- The President & CEO's acquisition of additional shares, even through a deferral plan, indicates continued alignment of management's interests with shareholders.
- The existence of multiple equity incentive plans (Stock-Based Deferral Plan, 2019 Equity Incentive Plan) suggests a structured approach to executive compensation and long-term retention.
Future Outlook
The filing details future vesting schedules for various stock awards and options granted under the Columbia Financial, Inc. 2019 Equity Incentive Plan, with vesting dates extending through March 2028 and option expiration dates through March 2035. A significant portion of these awards are performance-based, linking future compensation to company achievement.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction and does not provide broader industry context. It reflects standard executive compensation practices within the financial services sector, where equity awards are commonly used to incentivize long-term performance and align management with shareholder interests.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Details | The filing provides details on the Columbia Financial, Inc. 2019 Equity Incentive Plan, which governs the granting of stock awards and options to executives. This plan includes both time-based and performance-based vesting criteria, designed to align executive compensation with long-term company performance. | 2019 (Plan inception) | Strengthens corporate governance by linking executive incentives directly to shareholder value creation and long-term strategic objectives. |
Related Party Transactions
- Acquisition of 116.8059 shares of common stock by Thomas J. Kemly, President & CEO, through the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan.
- Granting of Stock Awards (II, III, IV) and Stock Options to Thomas J. Kemly under the Columbia Financial, Inc. 2019 Equity Incentive Plan, which are part of his executive compensation package.
Stakeholder Impact
- Shareholders: The acquisition of shares by the CEO, even through a deferral plan, can be viewed positively as it aligns management's financial interests with those of the shareholders, potentially fostering long-term value creation.
- Employees (Executives): The equity incentive plans provide long-term incentives and compensation for key management personnel, contributing to retention and performance motivation.
Next Steps
- Continued vesting of Stock Award II, with 25% vesting in three approximately equal annual installments commencing May 1, 2024, and the remaining 75% vesting upon achievement of specified performance-based criteria.
- Continued vesting of Stock Award III, with 25% vesting in three approximately equal annual installments commencing March 6, 2025, and the remaining 75% vesting upon achievement of specified performance-based criteria.
- Vesting of Stock Award IV upon achievement of specified performance-based criteria, with a potential vesting date of March 3, 2028.
- Continued vesting of stock options with an exercise price of $15.94, in three approximately equal annual installments commencing May 1, 2024.
- Continued vesting of stock options with an exercise price of $16.49, in three approximately equal annual installments commencing March 6, 2025.
- Continued vesting of stock options with an exercise price of $16.23, in three approximately equal annual installments commencing March 3, 2026.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date stock options with an exercise price of $15.6 became exercisable and fully vested. |
| 05/01/2024 | Commencement date for the first of three approximately equal annual installments for vesting of certain stock options (exercise price $15.94) and 25% of Stock Award II. |
| 03/06/2025 | Commencement date for the first of three approximately equal annual installments for vesting of certain stock options (exercise price $16.49) and 25% of Stock Award III. |
| 01/09/2026 | Transaction date for the acquisition of 116.8059 shares of common stock by Thomas J. Kemly. |
| 03/03/2026 | Commencement date for the first of three approximately equal annual installments for vesting of certain stock options (exercise price $16.23). |
| 03/03/2028 | Vesting date for Stock Award IV, contingent upon achievement of specified performance-based criteria. |
| 07/23/2029 | Expiration date for stock options with an exercise price of $15.6. |
| 05/01/2033 | Expiration date for stock options with an exercise price of $15.94. |
| 03/06/2034 | Expiration date for stock options with an exercise price of $16.49. |
| 03/03/2035 | Expiration date for stock options with an exercise price of $16.23. |
Recommendation
holdThis Form 4 reports a routine acquisition of shares by the CEO through a deferral plan and details existing equity awards. While insider buying can be a positive signal, this specific transaction is part of a pre-arranged plan and does not provide new fundamental information to change an investment thesis. Investors should 'hold' and consider this as a standard compensation-related disclosure rather than a strong market signal for immediate action.
Keywords
Columbia Financial, CLBK, Insider Transaction, Form 4, Stock Acquisition, CEO, Thomas J. Kemly, Equity Incentive Plan, Stock Options, Beneficial Ownership, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.